Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1985 2
1986 1
1987 4
1988 5
1989 9
1990 8
1991 5
1992 8
1993 13
1994 11
1995 28
1996 12
1997 13
1998 16
1999 22
2000 7
2001 7
2002 2
2003 3
2004 4
2005 3
2006 5
2007 5
2008 5
2009 2
2010 1
2011 1
2012 1
2015 1
2017 2
2018 1
2019 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

211 results
Results by year
Filters applied: . Clear all
Page 1
Central 5-HT4 receptors.
Eglen RM, Wong EH, Dumuis A, Bockaert J. Eglen RM, et al. Trends Pharmacol Sci. 1995 Nov;16(11):391-8. doi: 10.1016/s0165-6147(00)89081-1. Trends Pharmacol Sci. 1995. PMID: 8578609 Review.
The role of IP prostanoid receptors in inflammatory pain.
Bley KR, Hunter JC, Eglen RM, Smith JA. Bley KR, et al. Among authors: eglen rm. Trends Pharmacol Sci. 1998 Apr;19(4):141-7. doi: 10.1016/s0165-6147(98)01185-7. Trends Pharmacol Sci. 1998. PMID: 9612089 Review.
Muscarinic receptor antagonists.
Watson N, Eglen RM. Watson N, et al. Among authors: eglen rm. Pulm Pharmacol Ther. 1999;12(2):115-8. doi: 10.1006/pupt.1999.0185. Pulm Pharmacol Ther. 1999. PMID: 10373393 Review. No abstract available.
Peripheral 5-HT4 receptors.
Hegde SS, Eglen RM. Hegde SS, et al. Among authors: eglen rm. FASEB J. 1996 Oct;10(12):1398-407. doi: 10.1096/fasebj.10.12.8903510. FASEB J. 1996. PMID: 8903510 Review.
Overview of muscarinic receptor subtypes.
Eglen RM. Eglen RM. Handb Exp Pharmacol. 2012;(208):3-28. doi: 10.1007/978-3-642-23274-9_1. Handb Exp Pharmacol. 2012. PMID: 22222692 Review.
211 results